The randomized clinical trial “ACE2 Chewing Gum on SARS-CoV-2 Viral Load (COVID-19)” is still ongoing (https://clinicaltrials.gov/show/NCT05433181, accessed on 10 February 2023). This evidence concerns the gene ACE2 and COVID-19.